skip to content

Cockburn, Iain

Overview
Works: 23 works in 35 publications in 1 language and 82 library holdings
Classifications: H11,
Publication Timeline
Key
Publications about Iain Cockburn
Publications by Iain Cockburn
Most widely held works by Iain Cockburn
Price indexes for clinical trial research a feasibility study by Ernst R Berndt( Computer File )
1 edition published in 2013 in English and held by 26 libraries worldwide
We estimate hedonic price indexes for clinical trial research, an important component of biomedical R&D, using a large sample of agreements between trial sponsors and clinical investigators obtained from MediData Solutions Worldwide Inc. Nominal prices measured as total grant cost per patient rose by a factor of 4.5 between 1989 and 2011, while the NIH Biomedical R&D Price Index (BRDPI) focused on input costs rose only 2.2-fold. Most of the disparity appears to be attributable to changes in the nature and organization of clinical trials: during this period the average number of patients per site fell substantially while "site work effort" more than doubled. After controlling for these changes in the characteristics of investigator agreements using a variety of methods based on hedonic regressions, we find that the estimated rate of inflation in clinical trials costs tracks the BDRPI very closely. Results from this study suggest that it should be feasible for statistical agencies to develop a producer price index for this type of R&D activity, contributing to broader efforts to develop a deflator for contracted R&D services
Deals not done sources of failure in the market for ideas by Ajay Agrawal( file )
2 editions published in 2013 in English and held by 11 libraries worldwide
Using novel survey data on technology licensing, we report the first empirical evidence linking the three main sources of failure emphasized in the market design literature (lack of market thickness, congestion, lack of market safety) to deal outcomes. We disaggregate the licensing process into three stages and find that although lack of market thickness and deal failure are correlated in the first stage, they are not in the latter stages, underscoring the bilateral monopoly conditions under which negotiations over intellectual property often occur. In contrast, market safety is only salient in the final stage. Several commonly referenced bargaining frictions (congestion) are salient, particularly in the second stage. Also, universities and firms differ in the stage during which they are most likely to experience deal failure
Scale, scope and spillovers : the determinants of research productivity in drug discovery by Rebecca Henderson( Book )
4 editions published between 1993 and 1995 in English and held by 7 libraries worldwide
Measuring competence? : exploring firm effects in pharmaceutical research by Rebecca Henderson( Book )
3 editions published in 1994 in English and held by 4 libraries worldwide
Opportunity costs and entrepreneurial activity by Raphael Amit( Book )
1 edition published in 1994 in English and held by 4 libraries worldwide
Public & private spillovers, location and the productivity of pharmaceutical research by Jeffrey L Furman( Book )
2 editions published in 2006 in English and held by 4 libraries worldwide
While there is widespread agreement among economists and management scholars that knowledge spillovers exist and have important economic consequences, researchers know substantially less about the "micro mechanisms" of spillovers -- about the degree to which they are geographically localized, for example, or about the degree to which spillovers from public institutions are qualitatively different from those from privately owned firms (Jaffe, 1986; Krugman, 1991; Jaffe et al., 1993; Porter, 1990). In this paper we make use of the geographic distribution of the research activities of major global pharmaceutical firms to explore the extent to which knowledge spills over from proximate private and public institutions. Our data and empirical approach allow us to make advances on two dimensions. First, by focusing on spillovers in research productivity (as opposed to manufacturing productivity), we build closely on the theoretical literature on spillovers that suggests that knowledge externalities are likely to have the most immediate impact on the production of ideas (Romer, 1986; Aghion & Howitt, 1997). Second, our data allow us to distinguish spillovers from public research from spillovers from private, or competitively funded research, and to more deeply explore the role that institutions and geographic proximity play in driving knowledge spillovers
Good safety practice by Iain Cockburn( Book )
2 editions published in 2002 in English and held by 4 libraries worldwide
Why are some regions more innovative than others? the role of firm size diversity by Ajay Agrawal( file )
1 edition published in 2013 in English and held by 3 libraries worldwide
Large firms spawn spin-outs caused by innovations deemed unrelated to the firm's overall business. Small firms generate demand for specialized services that lower entry costs for others. We study the interplay of these two localized externalities and their impact on regional innovation. We examine MSA-level patent data during the period 1975-2000 and find that innovation output is higher in regions where large and small firms coexist. The finding is robust to across-region as well as within-region analysis and the effect is stronger in certain subsamples in a manner that is consistent with our explanation
Racing or spilling? : the determinants of research productivity in ethical drug discovery by Rebecca Henderson( Book )
2 editions published between 1993 and 1994 in English and held by 3 libraries worldwide
Racing to invest? : the dynamics of competition in ethical drug discovery by Iain Cockburn( Book )
2 editions published between 1993 and 1994 in English and held by 2 libraries worldwide
Exploring the diffusion of science driven drug discovery in pharmaceutical research by Iain Cockburn( Book )
2 editions published in 1999 in English and held by 2 libraries worldwide
Characteristics of demand for pharmaceutical products : an examination of four cephalosporins by Sarah Ellison( Book )
2 editions published between 1996 and 1997 in English and held by 2 libraries worldwide
Scale, scope, and spillovers : the determinants of research productuivity in drug discovery by Rebecca Henderson( Article )
1 edition published in 1996 in English and held by 1 library worldwide
Pharmaceutical innovations and market dynamics: tracking effects on price indexes for antidepressant drugs by Ernst R Berndt( Article )
1 edition published in 1996 in English and held by 1 library worldwide
Scale and scope in drug development : unpacking the advantages of size in pharmaceutical research by Iain Cockburn( Book )
1 edition published in 1996 in English and held by 1 library worldwide
New pills for poor people? : empirical evidence after GATT by Jean Olson Lanjouw( Article )
1 edition published in 2001 in English and held by 1 library worldwide
Concerns India more specifically
Untangling the origins of competitive advantage by Iain Cockburn( Book )
1 edition published in 2000 in English and held by 1 library worldwide
Measuring competence? Exploring firm effects in drug discovery by Rebecca Henderson( Article )
1 edition published in 2000 in English and held by 1 library worldwide
Public-private interaction in pharmaceutical research by Iain Cockburn( Book )
1 edition published in 1995 in English and held by 1 library worldwide
Loss of work productivity due to illness and medical treatment ( Book )
1 edition published in 1998 in English and held by 1 library worldwide
 
moreShow More Titles
fewerShow Fewer Titles
Languages
English (32)
Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.